Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of desloratadine 5 mg tablets relative to Aerius 5 mg tablets in healthy Thai volunteers under fasting conditions
TCTR20230811009Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desloratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20230811009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230811009.